Detalhe da pesquisa
1.
Magnesium sensing via LFA-1 regulates CD8+ T cell effector function.
Cell
; 185(4): 585-602.e29, 2022 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35051368
2.
Disturbed mitochondrial dynamics in CD8+ TILs reinforce T cell exhaustion.
Nat Immunol
; 21(12): 1540-1551, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33020660
3.
CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors.
Nat Immunol
; 21(3): 298-308, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32066953
4.
Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responses.
Immunity
; 56(6): 1341-1358.e11, 2023 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37315536
5.
Publisher Correction: Uncoupling protein 2 reprograms the tumor microenvironment to support the anti-tumor immune cycle.
Nat Immunol
; 20(4): 515-516, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30862953
6.
Uncoupling protein 2 reprograms the tumor microenvironment to support the anti-tumor immune cycle.
Nat Immunol
; 20(2): 206-217, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30664764
7.
High-throughput T cell receptor engineering by functional screening identifies candidates with enhanced potency and specificity.
Immunity
; 55(10): 1953-1966.e10, 2022 10 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36174557
8.
Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12.
Immunity
; 49(6): 1148-1161.e7, 2018 12 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30552023
9.
Hepatic stellate cells suppress NK cell-sustained breast cancer dormancy.
Nature
; 594(7864): 566-571, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34079127
10.
Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12.
Immunity
; 55(9): 1749, 2022 Sep 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36103861
11.
Optimized antiangiogenic reprogramming of the tumor microenvironment potentiates CD40 immunotherapy.
Proc Natl Acad Sci U S A
; 117(1): 541-551, 2020 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31889004
12.
Author Correction: Hepatic stellate cells suppress NK cell-sustained breast cancer dormancy.
Nature
; 600(7887): E7, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34764479
13.
Tumor mutational burden assessed by targeted NGS predicts clinical benefit from immune checkpoint inhibitors in non-small cell lung cancer.
J Pathol
; 250(1): 19-29, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31471895
14.
A highly efficient modality to block the degradation of tryptophan for cancer immunotherapy: locked nucleic acid-modified antisense oligonucleotides to inhibit human indoleamine 2,3-dioxygenase 1/tryptophan 2,3-dioxygenase expression.
Cancer Immunol Immunother
; 69(1): 57-67, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31802183
15.
PD-1+ natural killer cells in human non-small cell lung cancer can be activated by PD-1/PD-L1 blockade.
Cancer Immunol Immunother
; 69(8): 1505-1517, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32296919
16.
A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer.
Cancer Immunol Immunother
; 68(5): 799-812, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30770959
17.
Denosumab treatment is associated with the absence of circulating tumor cells in patients with breast cancer.
Breast Cancer Res
; 20(1): 141, 2018 11 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30458879
18.
The multi-receptor inhibitor axitinib reverses tumor-induced immunosuppression and potentiates treatment with immune-modulatory antibodies in preclinical murine models.
Cancer Immunol Immunother
; 67(5): 815-824, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29487979
19.
Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial.
Lancet
; 386(9998): 1049-56, 2015 Sep 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-26275735
20.
Metastatic spread in patients with non-small cell lung cancer is associated with a reduced density of tumor-infiltrating T cells.
Cancer Immunol Immunother
; 65(1): 1-11, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26541588